Ilex Medical Stock Current Valuation
| ILX Stock | 6,870 15.00 0.22% |
Valuation analysis of Ilex Medical helps investors to measure Ilex Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Ilex Medical's price fluctuation is very steady at this time. Calculation of the real value of Ilex Medical is based on 3 months time horizon. Increasing Ilex Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Ilex Medical is useful when determining the fair value of the Ilex stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Ilex Medical. Since Ilex Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ilex Stock. However, Ilex Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6870.0 | Real 7828.29 | Hype 6870.0 | Naive 6806.76 |
The real value of Ilex Stock, also known as its intrinsic value, is the underlying worth of Ilex Medical Company, which is reflected in its stock price. It is based on Ilex Medical's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Ilex Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ilex Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ilex Medical helps investors to forecast how Ilex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ilex Medical more accurately as focusing exclusively on Ilex Medical's fundamentals will not take into account other important factors: Ilex Medical Company Current Valuation Analysis
Ilex Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Ilex Medical Current Valuation | 901.49 M |
Most of Ilex Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ilex Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Ilex Medical has a Current Valuation of 901.49 M. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all Israel stocks is notably lower than that of the firm.
Ilex Medical is considered the number one company in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 914.01 Million. Ilex Medical totals roughly 901.49 Million in current valuation claiming about 99% of equities under Health Care industry.Ilex Fundamentals
| Return On Equity | 0.19 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 901.49 M | |||
| Shares Outstanding | 11.19 M | |||
| Shares Owned By Insiders | 62.44 % | |||
| Shares Owned By Institutions | 10.16 % | |||
| Price To Book | 1.83 X | |||
| Price To Sales | 1.16 X | |||
| Revenue | 1.06 B | |||
| Gross Profit | 379.38 M | |||
| EBITDA | 307.85 M | |||
| Net Income | 197.48 M | |||
| Cash And Equivalents | 118.65 M | |||
| Cash Per Share | 11.80 X | |||
| Total Debt | 1.28 M | |||
| Debt To Equity | 38.00 % | |||
| Current Ratio | 1.75 X | |||
| Book Value Per Share | 51.14 X | |||
| Cash Flow From Operations | 270.68 M | |||
| Earnings Per Share | 9.75 X | |||
| Number Of Employees | 254 | |||
| Beta | -0.11 | |||
| Market Capitalization | 1.01 B | |||
| Total Asset | 875.07 M | |||
| Annual Yield | 0.06 % | |||
| Five Year Return | 2.47 % | |||
| Net Asset | 875.07 M | |||
| Last Dividend Paid | 5.32 |
About Ilex Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ilex Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ilex Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ilex Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ilex Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Ilex Stock analysis
When running Ilex Medical's price analysis, check to measure Ilex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ilex Medical is operating at the current time. Most of Ilex Medical's value examination focuses on studying past and present price action to predict the probability of Ilex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ilex Medical's price. Additionally, you may evaluate how the addition of Ilex Medical to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |